C2 Flashcards

1
Q

Antimycobacterial drugs؟

A
Rifampin
Isonazide
Pyrazine.amide
Ethambutol
Streptomycin

Cycloserine
Dapson
Kanamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs for Tuberculosis?

A

RIPES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the MOA of antituberculotix?

what does it depends on?

A
  • Bactericidal or Bacteriostatic

- depending on drug concentration and strain susceptibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Isoniazid MOA?

A
  • Inhibits the synthesis of mycolic acids (cell walls)

- it is bactericidal for actively growing tubercle bacilli, but is less effective against dormants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Isonazid PharmacoKinetix?

A
  • absorption: well absorbed orally
  • metabolism: Liver (acetylation)
  • 1/2 life:
    *slow acetylators 3–4 h
    *fast acetylators 60–90m
    (for equivalent therapeutic effects fast acetylators require higher dosage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Isonazide clinical uses?

A
  • most important drug used in tuberculosis - component of most drug combination regimens
  • treats of latent infection
  • Prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Isonazide Toxicity?

A
  • peripheral neuritis
  • restlessness
  • muscle twitching
  • insomnia
  • RARE hepatotoxic ( jaundice, and hepatitis)
  • inhibit the hepatic metabolism of drugs (eg, carbamazepine, phenytoin, warfarin)
  • Hemolysis in G6PDH deficiency
  • Lupus-like syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rifampin MOA?

A
  • bactericidal
  • inhibits DNA-dependent RNApolymerase
  • if the drug is used alone, Resistance develops rapidly (changes in drug sensitivity of the polymerase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rifampin PharmacoKinetix?

A
  • absorption: well absorbed orally
  • distribution: most body tissues (even CNS)
  • metabolism: partially metabolized in the liver (enterohepatic cycling)
  • Elimination: feces (free drug and metabolites)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rifampin clinical uses?

A
  • always used in combination with other drugs when treating tuberculosis.
  • used as the sole drug in treatment of latent tuberculosis
  • in INH-intolerant patients or prophylaxis for INH-resistant strains
  • with dapson: In leprosy it is given monthly –> delays the emergence of resistance to dapsone.
  • with vancomycin: against MRSA or PRSP
  • meningococcal and staphylococcal carrier states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rifampin Toxicity?

A
  • Rifampin colors sweat, urine and tears orange
  • light-chain proteinuria
  • impair Ab responses
  • skin rashes
  • thrombocytopenia
  • nephritis
  • liver dysfunction
  • induces liver drug-metabolizing enzymes
  • enhances the elimination rate of many drugs (anticonvulsants, contraceptive steroids, cyclosporine, ketoconazole, methadone, terbinafine, and warfarin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ethambutol MOA?

A
  • inhibits arabinogalactan synthesis
    (cell walls)
  • if used alone, resistance develops rapidly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Etham butol PharmacoKinetix?

A
  • absorption: well absorbed orally
  • distribution: to most tissues (also CNS)
  • elimination: unchanged in the urine

In renal impairment dose reduction is necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ethambutol Clinical use?

A
  • tuberculosis

- always given in combination with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ethambutol Toxicity?

A
  • dose-dependent visual disturbances (regress when the drug is stopped)
  • headache, confusion, peripheral neuritis.
  • hyperuricemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pyrazinamide MOA?

A
  • MOA is not known :)
  • its bacteriostatic
  • Resistance develops rapidly when the drug is used alone
17
Q

Pyrazinamide PharmacoKinetix?

A
  • absorbtion: orally
  • distribution:most body tissues (also CNS)
  • metabolism: Liver.
  • Elimination: urine (drug and metabolite)

The plasma half-life of pyrazinamide is increased in hepatic or renal failure

18
Q

Pyrazinamide Clincal use?

A

short-course treatment regimens with other antituberculous drugs.

19
Q

Pyrazinamide Toxicity?

A
  • 40% of patients develop nongouty polyarthralgia
  • Hyperuricemia (asymptomatic)
  • myalgia
  • G.I. irritation
  • maculopapular rash
  • hepatic dysfunction
  • porphyria and photosensitivity reactions.

should be avoided in pregnancy

20
Q

Streptomycin?

A
  • Aminoglycoside used frequently against strains of M tuberculosis resistant to other drugs
  • principally used in drug combinations for the treatment of life-threatening tuberculous diseases
21
Q

Streptomycin pharmacodynamic and pharmacokinetic?

A

similar to those of other aminoglycosides

22
Q

streptomycin uses?

A
  • meningitis
  • miliary dissemination
  • severe organ tuberculosis
23
Q

cycloserine?

A

drug of limited use because of its toxicity:

  • peripheral neuropathy
  • CNS dysfunction
24
Q

Antitubercular standard Drug Regimens

A
  • For empiric treatment of pulmonary TB:
    initial 3-drug regimen of RIP recommended
  • If the organisms are fully susceptible
    (and HIV negative) –> pyrazinamide can be discontinued after 2m and treatment continued for 4m with a 2-drug regimen!
25
Q

Antitubercular Drug Alternative regimens?

A
  • fully susceptible organisms:
    1. RI 9m,
    2. RE 18m
    3. Intermittent (2 or 3/week) high-dose 4-drug regimens
26
Q

Antitubercular Drug Regimens Resistance?

A
  • If resistance to Isonszide is > 4% –> the initial drug regimen should include ethambutol or streptomycin.
  • Tuberculosis resistant only to isonazide (most common) –> 6m with a regimen of RPE/S
  • Multidrug-resistant organisms (both Isonazide + Rifampin) –> 3 or more drugs for a period > 18m (including 12m after sputum cultures become negative!)
27
Q

Drug for Leprosy?

A

Dapson

28
Q

What about Dapson?

A
  • DiAmino.diPhenyl.SulfONe) most active drug against M.Leprae.
  • it is recommended that the drug be used in combinations with Rifampin +/or Clofazimine (resistance)
29
Q

Dapson MOA?

A

inhibition of folic acid synthesis.

30
Q

Dapson PharmacoKinetix?

A
  • absorption: oral administration
  • Distribution: most tissues
  • metabolism: Liver (enterohepatic cycling)
  • elimination: urine
31
Q

Dapson Toxicity?

A
  • G.I. irritation
  • Fever
  • Skin rashes
  • methemoglobinemia
  • Hemolysis (with G6PDH deficiency)